모바일 헬스 앱 시장 예측(-2030년) : 제품 유형별, 플랫폼별, 기기별, 기술별, 용도별, 최종사용자별, 지역별 세계 분석

According to Stratistics MRC, the Global mHealth Apps Market is accounted for $37.8 billion in 2024 and is expected to reach $96.6 billion by 2030 growing at a CAGR of 16.9% during the forecast period. mHealth Apps are mobile applications that support healthcare services and information. They offer various health-related functionalities, such as health data collection, disease management, health education, telemedicine, and health monitoring. Benefits of mHealth apps include increased accessibility, improved patient engagement, enhanced convenience, and cost-effectiveness. These apps help manage chronic conditions, provide health education, enable remote consultations, and track fitness goals. They also reduce the need for in-person healthcare visits.

According to the Mobile Economy 2023 report, smartphone penetration was at 76% in 2022 and is predicted to reach 92% by 2030.

Market Dynamics:

Driver:

Increased demand for health monitoring

The increasing prevalence of chronic diseases like diabetes, hypertension, and heart disease necessitates continuous health monitoring through mHealth apps. These tools help patients track vital signs, manage symptoms, and manage treatment more effectively. Preventive healthcare is also gaining importance, with mHealth apps tracking fitness, nutrition, sleep, and overall wellness.

Restraint:

Attractive targets for cyber threats

mHealth apps are vulnerable to cybercriminals, leading to unauthorized access to personal health information (PHI), identity theft, financial loss, and privacy violations. Cyberattacks can compromise health data integrity, causing manipulated clinical measurements, misdiagnoses, and inappropriate treatments. Victims may experience anxiety, trauma, and vulnerability, which can exacerbate existing mental health conditions. Therefore, mHealth apps must be vigilant to protect sensitive health data.

Opportunity:

Increase in mobile subscriptions and internet penetration

mHealth apps have expanded their reach, reaching underserved populations in rural areas. This accessibility allows for real-time remote patient monitoring, improving care quality and facilitating timely interventions. The proliferation of smartphones and internet access has led to a surge in mHealth app downloads, reaching 3.7 billion, indicating significant revenue growth in the digital health sector. This growth in usage is particularly beneficial for chronic disease management.

Threat:

Technological barriers in developing regions

The digital divide and unequal distribution of devices and connectivity in developing regions hinder the widespread use of mobile health apps, limiting their potential user base and market growth. This raises concerns about equitable healthcare delivery. Additionally, inadequate health system readiness and lack of interoperability between mHealth apps and existing healthcare systems further hinder adoption. These challenges contribute to the digital divide and hinder the effectiveness and scalability of mHealth solutions.

Covid-19 Impact

The pandemic led to a surge in demand for remote healthcare, with mHealth apps becoming crucial for symptom tracking, telemedicine consultations, and managing chronic conditions. Governments and health organizations promoted these apps to raise awareness and encourage public adoption. The crisis altered perceptions of digital health technologies, making them more acceptable and necessary for healthcare providers and patients, potentially impacting future healthcare delivery models.

The medical apps segment is expected to be the largest during the forecast period

The medical apps is expected to be the largest during the forecast period as they aid in chronic disease management through remote monitoring, medication reminders, and health tracking. The rise in chronic conditions drives demand for mHealth solutions. Medical apps also boost user engagement by empowering users to take control of their health, leading to better health outcomes through features like telemedicine consultations and health tracking.

The chronic disease management segment is expected to have the highest CAGR during the forecast period

The chronic disease management segment is expected to have the highest CAGR during the forecast period as chronic diseases demand self-management tools like medication reminders, symptom tracking, and health data logging, leading to increased app usage and market growth. mHealth apps have expanded to include diseases like diabetes, hypertension, and cardiovascular issues, with nearly half of available apps designed for these conditions.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to increasing mobile usage & healthcare expenditure, growing 5G networks, and rising number of government initiatives & funding are driving the regional market growth. As per the World Bank statistics, the per capita national health expenditure in North America in 2022 was about USD 11,076.74. Furthermore, rising chronic disease prevalence and increasing geriatric population in the region are expected to support market growth.

Region with highest CAGR:

Asia Pacific is projected to witness the highest CAGR over the forecast period owing to increasing incidence of chronic & infectious diseases, rising healthcare expenditure, ineffective hospital service management, and a growing elderly population, are compelling governments & healthcare providers to develop new healthcare delivery models. For instance, in January 2024, JD Health introduced a new elderly care channel on its app to provide a comprehensive platform for the various healthcare needs of China's aging population.

Key players in the market

Some of the key players in mHealth Apps market include Abbott, AirStrip Technologies, Inc., Apple Inc, AstraZeneca, AT&T, Boston Scientific Corporation, Fitbit Inc, Google Inc., Johnson & Johnson Services, Inc., Livongo Health, Novartis AG, Omada Health, Inc., Omron Healthcare, Inc, Orange, Pfizer Inc., Qualcomm Technologies, Inc., Samsung Electronics Co. Ltd., Sanofi, Teladoc Health, Inc. and Veradigm LLC

Key Developments:

In September 2024, Abbott announced U.S. availability of Lingo(TM), the company's first continuous glucose monitoring system available without a prescription. Lingo is based on Abbott's world-leading FreeStyle Libre(R) continuous glucose monitoring technology1, now used by more than 6 million people with diabetes globally1.

In August 2024, Abbott announced the expansion of its Pure Bliss(TM) by Similac(R) line of organic, and European-made infant formulas that give parents a variety of products to meet specific formula preferences.

In June 2024, Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Silk Road Medical, Inc. (Nasdaq: SILK), a medical device company that has developed an innovative platform of products to prevent stroke in patients

Product Types Covered:

• Medical Apps
• Fitness Apps
• Other Product Types

Platforms Covered:

• iOS
• Android
• Cross-Platform
• Other Platforms

Devices Covered:

• Smartphones
• Tablets
• Wearables
• Health Monitoring Devices
• Computers and Laptops
• Other Devices

Technologies Covered:

• Artificial Intelligence (AI) & Machine Learning
• Big Data Analytics
• Wearable Technology Integration
• Internet of Things (IoT)
• Natural Language Processing (NLP)
• Biometric Sensors
• Other Technologies

Applications Covered:

• Fitness & Wellness
• Chronic Disease Management
• Mental Health
• Medication Adherence
• Health Records Management
• Healthcare Provider Integration
• Rehabilitation & Physical Therapy
• Other Applications

End Users Covered:

• Chronic Disease Patients
• Healthcare Providers
• Healthcare Institutions
• Elderly Care Providers
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Technology Analysis
• 3.8 Application Analysis
• 3.9 End User Analysis
• 3.10 Emerging Markets
• 3.11 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global mHealth Apps Market, By Product Type

• 5.1 Introduction
• 5.2 Medical Apps
  • 5.2.1 Women's Health Apps
  • 5.2.2 Personal Health Record Apps
  • 5.2.3 Medication Management Apps
  • 5.2.4 Diagnostic Apps
  • 5.2.5 Remote Monitoring Apps
  • 5.2.6 Disease Management Apps
  • 5.2.7 Other Medical Apps
• 5.3 Fitness Apps
  • 5.3.1 Diet & Nutrition
  • 5.3.2 Exercise & Fitness
  • 5.3.3 Lifestyle & Stress Management
• 5.4 Other Product Types

6 Global mHealth Apps Market, By Platform

• 6.1 Introduction
• 6.2 iOS
• 6.3 Android
• 6.4 Cross-Platform
• 6.5 Other Platforms

7 Global mHealth Apps Market, By Device

• 7.1 Introduction
• 7.2 Smartphones
• 7.3 Tablets
• 7.4 Wearables
• 7.5 Health Monitoring Devices
• 7.6 Computers and Laptops
• 7.7 Other Devices

8 Global mHealth Apps Market, By Technology

• 8.1 Introduction
• 8.2 Artificial Intelligence (AI) & Machine Learning
• 8.3 Big Data Analytics
• 8.4 Wearable Technology Integration
• 8.5 Internet of Things (IoT)
• 8.6 Natural Language Processing (NLP)
• 8.7 Biometric Sensors
• 8.8 Other Technologies

9 Global mHealth Apps Market, By Application

• 9.1 Introduction
• 9.2 Fitness & Wellness
• 9.3 Chronic Disease Management
• 9.4 Mental Health
• 9.5 Medication Adherence
• 9.6 Health Records Management
• 9.7 Healthcare Provider Integration
• 9.9 Rehabilitation & Physical Therapy
• 9.9 Other Applications

10 Global mHealth Apps Market, By End User

• 10.1 Introduction
• 10.2 Chronic Disease Patients
• 10.3 Healthcare Providers
• 10.4 Healthcare Institutions
• 10.5 Elderly Care Providers
• 10.6 Other End Users

11 Global mHealth Apps Market, By Geography

• 11.1 Introduction
• 11.2 North America
  • 11.2.1 US
  • 11.2.2 Canada
  • 11.2.3 Mexico
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 Italy
  • 11.3.4 France
  • 11.3.5 Spain
  • 11.3.6 Rest of Europe
• 11.4 Asia Pacific
  • 11.4.1 Japan
  • 11.4.2 China
  • 11.4.3 India
  • 11.4.4 Australia
  • 11.4.5 New Zealand
  • 11.4.6 South Korea
  • 11.4.7 Rest of Asia Pacific
• 11.5 South America
  • 11.5.1 Argentina
  • 11.5.2 Brazil
  • 11.5.3 Chile
  • 11.5.4 Rest of South America
• 11.6 Middle East & Africa
  • 11.6.1 Saudi Arabia
  • 11.6.2 UAE
  • 11.6.3 Qatar
  • 11.6.4 South Africa
  • 11.6.5 Rest of Middle East & Africa

12 Key Developments

• 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 12.2 Acquisitions & Mergers
• 12.3 New Product Launch
• 12.4 Expansions
• 12.5 Other Key Strategies

13 Company Profiling

• 13.1 Abbott
• 13.2 AirStrip Technologies, Inc.
• 13.3 Apple Inc.
• 13.4 AstraZeneca
• 13.5 AT&T
• 13.6 Boston Scientific Corporation
• 13.7 Fitbit Inc
• 13.8 Google Inc.
• 13.9 Johnson & Johnson Services, Inc.
• 13.10 Livongo Health
• 13.11 Novartis AG
• 13.12 Omada Health, Inc.
• 13.13 Omron Healthcare, Inc.
• 13.14 Orange
• 13.15 Pfizer Inc.
• 13.16 Qualcomm Technologies, Inc.
• 13.17 Samsung Electronics Co. Ltd.
• 13.18 Sanofi
• 13.19 Teladoc Health, Inc.
• 13.20 Veradigm LLC